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Abstract 31 
 32 
Multipotent neural stem cells (NSCs) provide a model to investigate neurogenesis 33 
and develop mechanisms of cell transplantation. In order to define improved markers 34 
of stemness and lineage specificity, we examined self-renewal and multi-lineage 35 
markers during long-term expansion and under neuronal and astrocyte differentiating 36 
conditions in human ESC-derived NSCs (hNSC H9 cells). In addition, with 37 
proteoglycans ubiquitous to the neural niche, we also examined heparan sulfate 38 
proteoglycans (HSPGs) and their regulatory enzymes. Our results demonstrate that 39 
hNSC H9 cells maintain self-renewal and multipotent capacity during extended 40 
culture and express HS biosynthesis enzymes and several HSPG core protein 41 
syndecans (SDCs) and glypicans (GPCs) at a high level. In addition, hNSC H9 cells 42 
exhibit high neuronal and a restricted glial differentiative potential with lineage 43 
differentiation significantly increasing expression of many HS biosynthesis enzymes. 44 
Furthermore, neuronal differentiation of the cells upregulated SDC4, GPC1, GPC2, 45 
GPC3 and GPC6 expression with increased GPC4 expression observed under 46 
astrocyte culture conditions. Finally, downregulation of selected HSPG core proteins 47 
altered hNSC H9 cell lineage potential. These findings demonstrate an involvement 48 
for HSPGs in mediating hNSC maintenance and lineage commitment and their 49 
potential use as novel markers of hNSC and neural cell lineage specification. 50 
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Introduction 60 
 61 
Neural stem cells (NSCs) are retained in the adult brain in discrete locations and 62 
maintain the ability to self-renew and differentiate into neural cell lineages - neurons, 63 
astrocytes and oligodendrocytes (Gage, 2000). Isolated NSCs can be propagated in 64 
vitro in the presence of fibroblast growth factor 2 (FGF-2) and epidermal growth 65 
factor (EGF) as free-floating neurospheres (Reynolds and Weiss, 1992) but can also 66 
be derived from embryonic stem cells (ESCs), which can be expanded as an 67 
adherent monolayer circumventing the challenges associated with long-term 68 
neurosphere culture (Conti et al., 2005, Zhang et al., 2001). NSCs provide a model 69 
of nervous system development and they have great therapeutic potential for the 70 
treatment of CNS injuries and disease. A better understanding of factors regulating 71 
their behaviour is required to fully exploit the capacity of these cells.  72 
 73 
NSCs with self-renewal and multipotentiality express the intermediate filament 74 
nestin, transcription factors SOX1 and SOX2 and the RNA-binding protein Musashi 1 75 
(MSI1), all shown to play a role in NSC self-renewal and thus in the maintenance of 76 
the NSC pool (Christie et al., 2013, Okano et al., 2005). In addition, the expression of 77 
telomerase (TERT) is considered a marker of true stem cell self-renewal (Thomson 78 
et al., 1998). Neuronal differentiation is indicated by increased expression of neuron-79 
specific markers including βIII-tubulin (TUBB3), microtubule-associated protein 2 80 
(MAP2), neurofilaments (NEFs) and doublecortin (DCX) (Brown et al., 2003, Laser-81 
Azogui et al., 2015, Song et al., 2002). Markers denoting the astrocyte lineage 82 
include glial fibrillary acidic protein (GFAP), surface marker CD44 and S100B 83 
calcium binding protein (Donato, 2001, Reeves et al., 1989, Sosunov et al., 2014) 84 
and finally, oligodendrocyte lineage markers include galactosylceramidase (GalC), 85 
transcription factors Olig1 and Olig2 and surface markers O1 and O4 (Barateiro and 86 
Fernandes, 2014, Tracy et al., 2011).  87 
 88 
However, there is an overlap in expression of these markers between lineages. For 89 
example nestin, MSI1 and MAP2, expressed by immature NSCs and neuronal cells 90 
are also expressed by reactive astrocytes (Duggal et al., 1997, Geisert et al., 1990, 91 
Oki et al., 2010) and Olig1 and Olig2 expressed by motor neurons with Olig2 are 92 
also shown to be required for NSC proliferation and maintenance (Ligon et al., 2007, 93 
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Zhou and Anderson, 2002). Thus, the identification of new lineage specification 94 
markers and/or defining novel combinations of markers would enable the more 95 
efficient utilisation of lineage-specific neural cells. 96 
 97 
The NSC microenvironment, or niche, plays a central role in regulating NSC 98 
stemness (self-renewal and differentiation) with local concentrations of signalling 99 
molecules mediating NSC maintenance and lineage differentiation (Ramasamy et 100 
al., 2013). The distribution and activity of extracellular signalling molecules is 101 
mediated by extracellular matrix (ECM) components, including proteoglycans (PGs). 102 
PGs consist of a core protein and attached sulfated glycosaminoglycan (GAG) 103 
chains that determine their classification and influence local concentrations of growth 104 
factors and ligands (Couchman and Pataki, 2012, Dreyfuss et al., 2009). The 105 
heparan sulfate proteoglycans (HSPGs) consist of two major families: the type I 106 
transmembrane syndecans (SDC1-4), and the globular GPI-anchored glypicans 107 
(GPC1-6) (Choi et al., 2011, Filmus et al., 2008).   108 
 109 
HS chains are synthesised post-translationally via a complex temporal process 110 
mediated by a number of biosynthesis enzymes to assemble chains to the core 111 
proteins. HS chains are first polymerised by exostosin glycosyltransferases 1 and 2 112 
(EXT1 and EXT2) (Busse et al., 2007), followed by modifications catalysed by N-113 
deacetylase/N-sulfotransferases (NDSTs; NDST1-4) and epimerisation catalysed by 114 
C5-epimerase (C5-EP) (Grobe et al., 2002). Finally, the HS chains are sulfated by 115 
HS 2-O-sulfotransferase (HS2ST1) and 6-O-sulfotransferases (HS6ST1, HS6ST2 116 
and HS6ST3), respectively (Esko and Selleck, 2002). HS chain length along with the 117 
N- and O-sulfation pattern subsequently determine the binding abilities of HSPGs 118 
(Esko and Selleck, 2002).  119 
 120 
SDCs and GPCs have been reported to regulate cell adhesion, migration and 121 
differentiation and demonstrate specific expression and localisation during CNS 122 
development (Choi et al., 2011, Ford-Perriss et al., 2003). The depletion of SDC1, 123 
GPC1 and GPC4 in vitro in mouse NSC or neural precursor cells alters cell 124 
maintenance and proliferation (Abaskharoun et al., 2010, Fico et al., 2012, Wang et 125 
al., 2012) and the depletion of EXT1, NDST1, HS2ST1 or HS6ST1 in the mouse 126 
CNS results in brain malformations and abnormalities (Grobe et al., 2005, Inatani et 127 
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al., 2003, Pratt et al., 2006). Currently the role of HSPGs in human NSC (hNSC) 128 
lineage specification is limited and reliant upon rodent models: despite the 129 
acknowledged differences in development, structure and regulation between human 130 
and rodent nervous systems (reviewed in (Oikari et al., 2014)). To elucidate key 131 
HSPGs in hNSC regulation we expanded hESC-derived NSCs (hNSC H9 cells) and 132 
examined the expression of NSC self-renewal and neural cell lineage markers along 133 
with HS biosynthesis enzymes and SDC and GPC core proteins in basal and lineage 134 
specific differentiation (neuronal and glial) cultures. Our results identify HSPGs as 135 
potential regulators of hNSC lineage potential and support their use as additional 136 
markers of neural cell specification. 137 
 138 
 139 
 140 
 141 
 142 
 143 
 144 
 145 
 146 
 147 
 148 
 149 
 150 
 151 
 152 
 153 
 154 
 155 
 156 
 157 
 158 
159 
 6 
Materials and Methods 160 
 161 
hNSC H9 cell expansion 162 
 163 
Two populations of human neural stem cells derived from the NIH approved H9 164 
(WA09) human embryonic stem cells (hNSC H9 cells) were purchased from Life 165 
Technologies and expanded until passage 31 (P31) corresponding to approximately 166 
100 days in culture. Basal culture conditions included expanding cells as a 167 
monolayer on Geltrex® coated culture vessels in neural stem cell serum-free 168 
medium (NSC SFM) containing KnockoutTM DMEM/F-12, 2% StemPro® Neural 169 
Supplement, 20 ng/mL of FGF-2 and EGF, and 2 mM GlutaMAXTM-I all obtained 170 
from GIBCO®, Life Technologies. Cells were maintained at 37°C in 5% CO2 in a 171 
humidified atmosphere and passaged every 3-5 days using TrypLE (Life 172 
Technologies) and re-plated at a density of 5x104 cells/cm2. The viability of the cells 173 
was monitored using Trypan Blue and an automated cell counter (Bio-Rad) and via 174 
hemacytometer. 175 
 176 
hNSC H9 neuron and astrocyte differentiation cultures  177 
 178 
hNSC H9 cells were cultured under lineage-specific differentiation conditions 179 
according to protocols provided by Life Technologies. For neuronal lineage 180 
differentiation, hNSC H9 cells were plated on poly-L-ornithine-laminin coated culture 181 
vessels at a seeding density of 2.5x104 cells/cm2; for astrocyte lineage 182 
differentiation, hNSC H9 cells were plated on Geltrex® coated culture vessels at a 183 
seeding density of 2x104 cells/cm2.  Cells were allowed to attach in NSC SFM for two 184 
days. Neuronal differentiation was induced by maintaining cells in Neurobasal® 185 
Medium (Life Technologies) supplemented with 2% B-27® Serum-Free Supplement 186 
and 2 mM GlutaMAXTM-I (Life Technologies) with the astrocyte differentiation 187 
conditions consisting of DMEM supplemented with 1% N-2 supplement (Life 188 
Technologies), 2 mM GlutaMAXTM-I and 1% FBS. Cells were maintained in 189 
differentiating conditions for 15 to 18 days with the medium changed every 3-4 days.  190 
 191 
RNA-interference 192 
 193 
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hNSC H9 P5 cells were plated in NSC SFM at a density of 5x104 cells/cm2 and 194 
allowed to attach for 48h prior to treatment with AccellTM Smartpool Human siRNAs 195 
(Dharmacon), a pool of four siRNA transcripts specific to GPC1 (E-004303-00-0010) 196 
or GPC4 (E-011271-00-0010). For siRNA delivery, the growth medium was changed 197 
to AccellTM siRNA Delivery Media containing 1 μM of siRNA supplemented with 2% 198 
StemPro® Neural Supplement and 20 ng/mL of FGF-2 and EGF. Untreated and 199 
non-targeting (scramble) siRNA (D-001910-10-20) treated cells were used as a 200 
control. Cells were incubated with siRNAs for 72h after which cell number and 201 
viability was assessed and cells harvested for RNA extraction. 202 
 203 
Total RNA extraction, cDNA synthesis and Q-PCR  204 
 205 
RNA was harvested using TRIzol® reagent (Invitrogen) with the Direct-zolTM RNA 206 
miniprep kit (Zymo Research) according to the manufacturer’s instructions. During 207 
extraction samples were treated in-column with DNase I (Zymo Research) for 15 min 208 
to eliminate DNA contamination. cDNA synthesis was performed using Roche 209 
Transcriptor Reverse Transcriptase. Briefly, 150 ng of RNA was incubated with 3 µg 210 
of Random Primer (Invitrogen) at 65°C for 10 min in a reaction volume of 19.5 μl. 211 
Samples were then incubated with 10 U of RT enzyme in 1x RT reaction buffer, with 212 
1 mM dNTPs (New England Biolabs), 20 U of RNaseOUT (Invitrogen) in a total 213 
reaction volume of 30 μl for 10 min at 25°C, followed by 30 min at 55°C and a final 214 
step of 5 min at 85°C.  215 
 216 
Q-PCR reactions were performed in quadruplicate per sample for each gene studied 217 
in a 384-well microtiter plate. Each reaction contained 120 ng of cDNA template, 5 μl 218 
of SYBR®-Green PCR Master Mix (Promega), 200 ng of forward and reverse primer 219 
and 0.1 μl of CXR reference dye (Promega). Amplification was monitored using a 220 
Life Technologies QuantStudioTM-7 with an enzyme activation of 2 min at 50°C and 3 221 
min at 95°C followed by 50 cycles of 15 s at 95°C and 1 min at 60°C. Cycle 222 
threshold (Ct) values were normalised against the endogenous control gene 18S Ct 223 
values (ΔCt) included in each run. Relative gene expression was determined by 224 
calculating the ΔΔCt value (2(-ΔCt)) and relative expression values presented on bar 225 
graphs are ΔΔCtx106. All primer sequences for the genes studied can be found in 226 
tables 1 and 2 in (Oikari et al., 2015).  227 
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 228 
Immunofluorescence 229 
 230 
For immunofluorescent (IF) detection of target proteins, cells in basal growth 231 
conditions were plated on CC2-coated chamber slides (Lab-Tek) at 5x104 232 
cells/chamber and allowed to attach for 2 days.  Differentiating cells were plated in 233 
48-well culture dishes (Corning) and stained between D14-D18. Prior to staining, 234 
cells were washed with 1X PBS with Ca2+ and Mg2+ and fixed with 4% 235 
paraformaldehyde then blocked with 1% BSA and 5% donkey serum in 1X PBS with 236 
Ca2+ and Mg2+. For intracellular proteins 0.1% of Triton-X was included in the 237 
blocking solution to allow permeabilisation. After blocking, primary antibodies diluted 238 
in blocking solution were applied to cultures and incubated overnight at 4°C. The 239 
following primary antibodies and dilutions were used: anti-Nestin (ab22035, Abcam, 240 
1:200), anti-SOX2 (AB5603, Millipore, 1:1000), anti-TUBB3 (ab18207, Abcam, 241 
1:1000), anti-S100B (ab868, Abcam, 1:200), anti-O1 (MAB344, Millipore, 1:500), 242 
anti-syndecan 4 (ab24511, Abcam, 1:1000), anti-glypican 1 (ab137604, Abcam, 243 
1:1000), anti-glypican 4 (ab100843, Abcam, 1:500) and 10E4 HS antibody (370255-244 
S, amsbio 1:500). After overnight incubation cells were washed with 1X PBS with 245 
Ca2+ and Mg2+ secondary antibodies applied and cells incubated at room 246 
temperature for 2h. Finally, cells were rinsed with 1X PBS with Ca2+ and Mg2+, and 247 
counterstained with fluoroshield mounting medium with DAPI (ab104139, Abcam). 248 
Images were taken on an Olympus IX81 inverted phase-contrast fluorescent 249 
microscope using Volocity software (Perkin Elmer) on a Hamamatsu Orca camera. 250 
Isotype controls and secondary antibodies used can be found in table 3 in (Oikari et 251 
al., 2015).  252 
 253 
Western blotting 254 
 255 
Total protein was extracted using protein-lysis buffer (20 mM HEPES, 25% Glycerol, 256 
1.5 mM MgCl2, 420 mM NaCl, 0.5 mM DTT, 0.2 mM EDTA, 0.5% Igepal CA-630, 0.2 257 
mM Na3VO4, 1 mM PMSF and dH2O containing protease and phosphatase 258 
inhibitors). Protein concentration was determined using the BCA protein quantitation 259 
assay (Pierce) with ~50 μg of total protein separated by SDS-PAGE using 12% pre-260 
cast gels (Mini-PROTEAN®TGXTM, Bio-Rad). For the detection of HSPG core 261 
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proteins using the monoclonal antibody HS Δ3G10, protein samples were treated 262 
with 1.5 mU Heparitinase (Seikagaku Biobusiness) for 2.5h at 37°C before 263 
separation. After separation, protein was transferred to a PVDF membrane, the 264 
membrane blocked with 5% milk and primary antibodies diluted in 5% BSA 265 
incubated on the membrane overnight.  Primary antibodies used were: anti-SOX2 266 
(#AB5603, Millipore), anti-TUBB3 (ab18207, Abcam), anti-CD44 (ab6124, Abcam), 267 
anti-Δ3G10 (H1890-75, US Biological) and anti-GAPDH (#2118, Cell Signaling) as 268 
loading control.  The membrane was then washed with TBST and incubated with 269 
HRP-conjugated secondary antibodies (anti-Rabbit IgG, #7074 and anti-Mouse IgG, 270 
#7076, both from Cell Signaling) diluted in 5% BSA for 2h at room temperature. 271 
Detection of target proteins was performed with ECL (ClarityTM ECL, Bio-Rad) using 272 
the Fusion FX Spectra chemiluminescence system (Vilber Lourmat, Fisher Biotec) 273 
with optical quantitation performed using Bio-1D software.  274 
 275 
Statistical analysis 276 
 277 
Expansion, differentiation and RNA-interference (RNAi) experiments consisted of 278 
two biological replicates (hNSC H9 POP1 and POP2) with RNA and protein samples 279 
of differentiated and RNAi cultures consisting of 2-4 pooled wells. For IF images the 280 
average signal intensity was calculated by normalising the mean signal intensity to 281 
exposure time and dividing it by the number of nuclei.  The signal intensities and 282 
nuclei count were obtained using Volocity software and values presented are an 283 
average between 2-4 images. Statistical significance was determined using a paired 284 
t-test and defined as * p<0.5, ** p<0.01 and *** p<0.001.  285 
 286 
 287 
 288 
 289 
290 
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Results 291 
 292 
hNSC H9 expansion and lineage characterisation 293 
 294 
Commercially available hNSC H9 cells (POP1 and POP2) were independently 295 
established and expanded as a monolayer on Geltrex® until passage 31 (P31) 296 
corresponding to approximately 100 days in culture (Fig. 1A). Cells were passaged 297 
at 90-100% confluence approximately every 3-4 days and re-plated at a seeding 298 
density of 5x104 cells/cm2.  Cell number and viability was assessed using Trypan 299 
Blue on an automated cell counter as well as via hemacytometer with morphology of 300 
the cells monitored under a phase contrast microscope and images taken at each 301 
passage at D1. For gene expression analysis, RNA was harvested from both 302 
populations at passages 2, 5, 7, 11, 13, 17, 21, 23, 27/28 and 31 and gene 303 
expression results presented as the average for both populations at passages P2-304 
P5, P7-P11, P13-P17, P21-23 and P27-P31. 305 
 306 
Cells exhibited linear growth and a high level of homogeneity throughout expansion 307 
(Fig. 1A-B). A similar growth rate was observed for both populations until P6, after 308 
which POP2 grew faster with P31 reached at D87 with POP1 reaching P31 after 105 309 
days in culture (Fig. 1A). The averaged viability for both populations remained 310 
between 60-84% with decreased viability observed between P2 (84%) and P31 311 
(60%) (Fig. 1A). Cells acquired minimal morphological changes between P2, P5, 312 
P17 and P31 (corresponding to averaged 2, 12, 52 and 96 days in culture) (Fig. 1B) 313 
and maintained human TERT (hTERT) expression, with no significant change 314 
observed in expression between P27-P31 and P2-P5 (Fig. 1C). 315 
 316 
Expanded hNSC H9 cultures were examined for expression of NSC self-renewal as 317 
well as neural specific lineage markers at passages P2-P5, P7-P11, P13-P17, P21-318 
P23 and P27-P31. NSC markers nestin, SOX1, SOX2 and MSI1 gene expression 319 
was observed throughout expansion (Fig. 2A). SOX2 was expressed at the highest 320 
level and its expression significantly upregulated (p=0.008) in P27-P31 cultures 321 
when compared to P2-P5. Neuronal markers TUBB3, MAP2, medium molecular 322 
weight NEF (NEFM) and DCX were expressed during expansion with TUBB3 323 
demonstrating the highest expression level, followed by MAP2, NEFM and DCX, 324 
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respectively (Fig. 2B). TUBB3 (p=0.002) and MAP2 (p=0.02) were significantly 325 
upregulated at late passages (P27-P31) when compared to early passage (P2-P5) 326 
cells. 327 
 328 
hNSC H9 cells also expressed glial markers, denoting astrocyte (S100B and CD44) 329 
and oligodendrocyte (GalC, Olig1 and Olig2) lineages (Fig. 2C-D). The observed 330 
expression levels of glial markers remained markedly lower than neuronal markers 331 
with the neuronal marker TUBB3 (>50x106) expressed approximately at a 50 times 332 
higher level than the glial markers (~1x106) at P2-P5. Significant upregulation of the 333 
astrocyte marker S100B (p=0.0008) and oligodendrocyte markers Olig1 (p=0.04) 334 
and Olig2 (p=0.007) in late passages (P27-P31) was observed (Fig. 2C-D) with 335 
GFAP expression absent or only intermittently present in a few passages (data not 336 
shown).  337 
 338 
We then examined the cultures for expression of a panel of NSC and neural cell 339 
lineage markers via IF. NSC markers nestin and SOX2 as well as neuronal (TUBB3), 340 
astrocyte (S100B) and oligodendrocyte (O1) markers were observed at early (P5), 341 
mid (P17) and late (P31) passages (Fig. 2E).  Nestin, SOX2 and TUBB3 342 
demonstrated a homogeneous expression pattern with S100B showing high 343 
expression only in a few cells and the average signal intensity for O1 was the lowest 344 
when compared to other markers studied (Fig. 2F). Increased SOX2 expression was 345 
demonstrated via Western analysis indicative of self-renewal during extended culture 346 
(Fig. 2G). The combined expression profile of neuronal, astrocyte and 347 
oligodendrocyte lineage markers examined demonstrate hNSC H9 cells maintain 348 
multipotentiality during extended in vitro expansion.   349 
 350 
HSPGs during hNSC H9 expansion 351 
 352 
Following confirmation of maintenance of self-renewal and expression of multi-353 
lineage markers during long-term expansion we then studied the expression of HS 354 
regulatory enzymes and SDCs and GPCs in hNSC H9 cells from early (P2-P5) to 355 
late stages (P27-P31) of expansion. HS biosynthesis genes were expressed in 356 
hNSC H9 cells including elongation (EXT1 and EXT2), modification (NDST1-4 and 357 
C5-EP) and sulfation (H2ST1, HS6ST1-3) enzymes with clear differences in 358 
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expression levels observed between several of the enzymes (Fig. 3A-D). This 359 
included higher relative expression of EXT1 than EXT2 with EXT1 expression 360 
significantly downregulated (p=0.02) in late passage cultures (P27-P31) (Fig. 3A). 361 
NDST1 demonstrated the highest expression level followed by NDST2 with NDST3 362 
and NDST4 expressed at a low level (Fig. 3B). Of the sulfotransferases HS2ST1 was 363 
most highly expressed, followed by HS6ST1, HS6ST2 and HS6ST3, respectively 364 
(Fig. 3D). In addition, HS2ST1 expression was significantly downregulated (p=0.01) 365 
and HS6ST2 significantly upregulated (p=0.03) in late passage cultures.   366 
 367 
HSPG core protein SDC2 demonstrated the highest expression level followed by 368 
SDC3, SDC1 and SDC4, respectively (Fig. 3E) in hNSC cultures. Both SDC2 369 
(p=0.03) and SDC3 (p=0.02) significantly increased expression at late passages 370 
(P27-P31) when compared to early passages (P2-P5) (Fig. 3E). GPC1, GPC2, 371 
GPC3, GPC4 and GPC6 were expressed in hNSC H9 cultures, but no GPC5 372 
expression was detected (Fig. 3F). GPC4 was most abundantly expressed followed 373 
by GPC1, GPC2, GPC3 and GPC6, respectively (Fig. 3F). The expression of GPC2 374 
(p=0.0003) and GPC4 (p=4.3e-5) was highly significantly increased in later passage 375 
(P27-P31) cultures. Detection of the HS 10E4-epitope via IF demonstrated localised 376 
HS providing further confirmation that hNSC H9 cells maintain HS expression 377 
throughout expansion (P5 to P31) (Fig. 3G).  378 
 379 
Markers of hNSC H9 neuronal and astrocyte lineage differentiation 380 
 381 
In order to confirm hNSC multipotency and to identify any associated changes in the 382 
HSPG profile following lineage commitment, cells were examined during neuronal 383 
and astrocyte differentiating conditions. Due to low differentiation efficiency and poor 384 
viability of the cells following initiation of oligodendrocyte differentiation, this lineage 385 
was not further examined. Neuronal and astrocyte differentiation was induced for 14-386 
18 days in both populations in P5 cells and during differentiation, cells were 387 
monitored for morphological changes as well as expression changes in lineage and 388 
HSPG genes.  389 
 390 
Cells cultured in neuronal differentiating conditions acquired thin, elongated 391 
protrusions, while astrocyte lineage cultures exhibited a large cell body when 392 
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compared to basal and neuronal cultures (Fig. 4A). Gene expression levels of the 393 
NSC markers nestin, SOX1 and SOX2 were not altered following differentiation while 394 
MSI1, also a marker of reactive astrocytes, was highly significantly upregulated in 395 
astrocyte cultures when compared to basal (p=7.2e-6) and neuronal (p=0.0001) 396 
cultures  (Fig. 4B). All neuronal markers examined were significantly upregulated in 397 
neuronal cultures when compared to basal cultures including: TUBB3 (p=0.03), 398 
MAP2 (p=0.02), NEFM (p=0.0006) and DCX (p=0.02) (Fig. 4C). Furthermore, NEFM 399 
(p=0.002) and DCX (p=0.03) were significantly upregulated in neuronal cultures 400 
when compared to astrocyte cultures (Fig. 4C). Interestingly, TUBB3 (p=0.009), 401 
MAP2 (p=5.8e-8), NEFM (p=0.01) and DCX (p=0.03) were also upregulated in the 402 
astrocyte cultures when compared to basal cultures, however, the expression level 403 
of NEFM and DCX in astrocyte cultures remained lower than in neuronal cultures 404 
(Fig. 4C). The astrocyte marker S100B was undetectable by Q-PCR in neuronal 405 
cultures, while it was highly significantly upregulated (p=6e-5) in astrocyte cultures 406 
when compared to basal cultures (Fig. 4D). In addition, the glial marker CD44 was 407 
significantly upregulated in both neuronal (p=0.008) and astrocyte (p=0.0003) 408 
cultures when compared to basal hNSC H9 cells, with higher relative expression 409 
observed in neuronal cultured cells (Fig. 4D). Western analysis confirmed 410 
upregulation of TUBB3, SOX2 and CD44 in neuronal cultures when compared to 411 
both basal and astrocyte cultures (Fig. 4E). No protein level expression of the 412 
astrocyte marker S100B was observed under any culture conditions.  413 
 414 
IF demonstrated that the neuronal cultures exhibited significantly decreased average 415 
signal intensity of nestin (vs. hNSC H9 p=0.04, vs. astrocyte p=0.005) and SOX2 (vs. 416 
hNSC H9 p=0.048, vs. astrocyte p=0.029) compared to other culture conditions with 417 
astrocyte cultures demonstrating increased nestin intensity compare to basal 418 
cultures (p=0.02) (Fig. 4F-G). Furthermore, although not significant, neuronal 419 
cultures demonstrated the highest TUBB3 signal intensity compared to other 420 
conditions and a significantly decreased signal intensity of S100B compared to basal 421 
(p=0.008) and astrocyte (p=0.03) cultures. The average signal intensity of S100B in 422 
astrocyte cultures remained lower than in basal cultures (p=0.008) (Fig. 4G), 423 
however, a high number of cells demonstrated strong S100B staining in these 424 
cultures (Fig. 4F).  425 
 426 
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Lineage specific changes in HSPG expression 427 
 428 
Multiple HS biosynthesis enzymes exhibited a significant increase in expression 429 
when examined by Q-PCR following neuronal and astrocyte lineage differentiation. 430 
The HS polymerising enzyme EXT2 was highly significantly upregulated in neuronal 431 
cultures when compared to both basal (p=4.2e-5) and astrocyte (p=0.0001) cultures 432 
and the HS modifying enzyme C5-EP was significantly upregulated in neuronal 433 
cultures when compared to astrocyte cultures (p=0.02) (Fig. 5A). Following lineage 434 
commitment NDST2 was significantly upregulated (p=0.04) in neuronal cultures 435 
compared to basal and astrocyte cultures; NDST3 was significantly upregulated in 436 
both neuronal and astrocyte (p=0.003) cultures compared to basal cultures, with a 437 
significant difference also observed between neuronal and astrocyte cultures 438 
(p=0.04); and finally, NDST4 was highly significantly upregulated in neuronal 439 
cultures when compared to basal (p=4.1e-5) and astrocyte (p=0.0006) cultures (Fig. 440 
5B). The expression level of HS2ST1 was not altered following hNSC H9 cell 441 
differentiation, however, HS6ST2 (p=0.006) and HS6ST3 (p=0.02) were significantly 442 
upregulated in neuronal cultures when compared to basal cultures with HS6ST2 also 443 
significantly upregulated (p=0.03) in neuronal cultures when compared to astrocyte 444 
cultures (Fig. 5C). Finally, HS6ST1 (p=0.049) and HS6ST2 (p=0.013) were 445 
significantly upregulated following astrocyte lineage differentiation when compared to 446 
basal hNSC H9 cultures (Fig. 5C).  447 
 448 
Gene expression of SDC1, SDC2 and SDC3 were not altered following neuronal 449 
differentiation, interestingly, however, SDC4 expression was significantly 450 
upregulated (P=0.03) in neuronal cultures when compared to basal and astrocyte 451 
cultures (Fig. 5D). In addition, SDC2 was significantly upregulated (p=0.011) in 452 
astrocyte cultures when compared to neuronal cultures (Fig. 5D). Significant 453 
increases in expression were observed for several GPCs in neuronal cultures when 454 
compared to basal and astrocyte cultures as follows: GPC1 neuronal vs. basal 455 
(p=0.049), neuronal vs. astrocyte (p=0.048); GPC2 neuronal vs. basal (p=0.009) and 456 
neuronal vs. astrocyte (p=0.011); GPC3 neuronal vs. basal (p=0.014) and neuronal 457 
vs. astrocyte (p=0.013); and GPC6 neuronal vs. basal (p=0.009) and neuronal vs. 458 
astrocyte (p=0.02) (Fig. 5E). GPC4 was highly significantly upregulated in astrocyte 459 
differentiating cultures when compared to basal (p=0.0001) and neuronal (p=1.8e-5) 460 
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cultures with GPC6 also showing significant upregulation (p=0.02) in the astrocyte 461 
cultures when compared to basal cultures (Fig. 5E). Finally, the HS Δ3G10 epitope 462 
was detected in basal and lineage differentiated cultures via a Western analysis 463 
following heparitinase digest with three major bands representing multiple HSPGs 464 
associated with the cell membrane of approximately 70 kDa (glypicans), 35 kDa and 465 
15 kDa (syndecans) (Haupt et al., 2009). Relative quantitation normalised to GAPDH 466 
demonstrated higher intensity for the 70 kDa band in neuronal and astrocyte cultures 467 
with the 35 kDa and 15 kDa bands demonstrating higher intensity in the basal 468 
cultures suggesting HSPG modifications during lineage commitment.  469 
 470 
SDC4, GPC1 and GPC4 were further examined via IF under all culture conditions 471 
demonstrating cellular localisation. Neuronal differentiating cultures demonstrated 472 
strong SDC4 and GPC1 staining. Although the average signal intensity of these 473 
markers was not significantly higher to basal cells, GPC1 demonstrated significantly 474 
stronger staining in neuronal cells when compared to astrocyte cultures (p=0.03). 475 
(Fig. 6A). While IF of GPC4 did not demonstrate significantly higher signal intensity 476 
in the astrocyte cultures, high levels of expression were localised to areas of dense 477 
cell-cell contact reflective of the observed phenotypic changes when compared to 478 
the basal and neuronal cells (Fig. 6A). Finally, to examine the potential influence of 479 
GPC1 and GPC4 on hNSC H9 lineage potential, we downregulated the expression 480 
of these core proteins in undifferentiated hNSC H9 P5 cells at the mRNA level using 481 
gene specific RNAi pools and studied changes in marker genes in the knockdown 482 
(KD) cultures compared to control conditions (untreated and scramble). GPC1kd and 483 
GPC4kd cultures expressed significantly reduced levels of GPC1 (p=1.6e-10, 58% 484 
reduction to control) and GPC4 (p=9.3e-8, 73% reduction to control), respectively, 485 
with no changes observed in cell number or viability when compared to control 486 
cultures (Fig. 6B). KD of GPC1 significantly reduced the gene expression levels of 487 
nestin (p=0.005), MSI1 (p=0.004), TUBB3 (p=0.004) and NEFM (p=0.003) with the 488 
KD of GPC4 significantly reducing NEFM (p=0.03) and S100B (p=0.004) gene 489 
expression (Fig. 6C-D).  490 
 491 
 492 
 493 
 494 
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Discussion 495 
 496 
Self-renewing and multipotent hNSCs provide an in vitro model to study human 497 
neurogenesis and have potential in the regenerative treatment of CNS injuries. 498 
Understanding the mechanisms regulating expansion, ‘stemness’ and lineage 499 
commitment of hNSCs is critical to our improved understanding of the cells for these 500 
applications. With the extracellular microenvironment contributing to the regulation of 501 
stem cell fate, cell-surface HSPGs associated with hNSCs and localised within the 502 
neural niche may provide novel markers for the characterisation and isolation of 503 
hNSCs and their progeny and with which to control hNSC lineage specification. The 504 
central findings of this study are summarised in figure 7, with several HSPGs 505 
proposed as novel markers of hNSCs and lineage specificity.  506 
 507 
hNSC expansion, stemness, multi-lineage capacity and HSPGs  508 
 509 
With limitations associated with the long-term culture of brain-derived neurospheres 510 
(Anderson et al., 2007, Ostenfeld et al., 2000, Wright et al., 2006, Zhang et al., 511 
2001), we utilised adherent hESC-derived NSCs (hNSC H9 cells) as a model of NSC 512 
self-renewal and neurogenesis. During extended culture limited morphological 513 
changes were observed in the cells with cultures continuing to express hTERT as 514 
well as increased NSC self-renewal (SOX2) and neural lineage marker expression, 515 
(TUBB3, MAP2, S100B, Olig1 and Olig2) (Fig. 7) suggesting the cells maintain 516 
stemness and multipotency. Previous studies utilising human neural progenitor cells 517 
(NPCs) isolated from the cortical tissue have demonstrated the loss of neurogenic 518 
potential during extended culture as indicated by downregulation of neuronal 519 
markers, such as TUBB3 and upregulation of glial markers, such as S100B 520 
(Anderson et al., 2007, Wright et al., 2006), While glial markers were also 521 
upregulated in hNSC H9 cells during long-term expansion, these cells appear to also 522 
retain their self-renewal and neuronal differentiative potential (SOX2, TUBB3 and 523 
MAP2) highlighting the advantage of utilising hESC-derived NSCs as a self-renewing 524 
NSC model.    525 
 526 
HSPG ECM proteins including biosynthesis enzymes and cell-anchored SDCs and 527 
GPCs regulate multiple cellular functions and are potential targets for the control of 528 
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hNSC fate. The expression of central HS synthesising and modifying EXT1, NDST1 529 
and HS2ST1 (Busse et al., 2007, Grobe et al., 2002, Kreuger and Kjellen, 2012) in 530 
basal hNSC H9 cultures suggests active production of HS chains. The observed 531 
decrease in expression of EXT1 and HS2ST1 during extended culture likely reflects 532 
reduced synthesis of new HS chains with the increased 6-O-sulfation suggesting 533 
continued modification of the HS chains (Fig. 7). HS chain modifications are 534 
associated with a shift in growth factor binding abilities (e.g. FGF-2 vs. FGF-1) 535 
(Brickman et al., 1998, Johnson et al., 2007), indicating altered requirements in 536 
hNSC H9 cells during expansion.  537 
 538 
Of the SDC and GPC core proteins, SDC1, SDC2, SDC3, GPC1 and GPC4 539 
demonstrated high expression in basal hNSC H9 cells with extended culture 540 
upregulating SDC2, SDC3, GPC2 and GPC4 expression (Fig. 7). In addition, KD of 541 
GPC1 downregulated the expression of nestin in basal hNSC H9 cells. Previous 542 
reports have shown SDC1, GPC1 and GPC4 to be required for mouse NPC and 543 
ESC maintenance and SDC2 and SDC3 have been shown to localise to rodent 544 
neurons and NSCs (Abaskharoun et al., 2010, Fico et al., 2012, Ford-Perriss et al., 545 
2003, Hienola et al., 2006, Inatani et al., 2001, Wang et al., 2012) suggesting these 546 
HSPGs  are likely key contributors to the hNSC niche. Continued dissection of the 547 
function of these HSPGs within the neural niche will allow us to more fully 548 
understand their contribution to both stemness and lineage specification.  549 
 550 
Markers and HSPGs of neuronal differentiation of hNSCs 551 
 552 
Understanding markers of neurogenesis is crucial for more efficient neuronal lineage 553 
differentiation of hNSCs. High expression levels of neuronal markers in basal hNSC 554 
H9 cells indicated the high inherent neuronal potential of these cells, confirmed by 555 
upregulation of the neuronal markers examined in neuronal lineage differentiative 556 
culture conditions. Specific neuronal markers upregulated in neuronal lineage cells 557 
when compared to both basal and astrocyte lineage cells, included TUBB3 (protein 558 
level), NEFM (transcript) and DCX (transcript) (Fig. 7). Interestingly, MAP2 which is 559 
commonly used to characterise neuronal lineage cells (Song et al., 2002), was highly 560 
upregulated in astrocyte cultures and showed no significant difference in expression 561 
between neuronal and astrocyte cultures. This supports previous reports of MAP2 562 
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functioning as a reactive astrocyte marker (Geisert et al., 1990) indicating its lack of 563 
specificity to the neuronal lineage.  564 
 565 
Neuronal differentiation of hNSC H9 cells induced the expression of multiple HS 566 
biosynthesis enzymes, including EXT2, NDST2, NDST4, HS6ST2 and HS6ST3 567 
indicating altered HS biosynthesis activity following neuronal commitment (Fig. 7). 568 
The upregulation of these enzymes has been reported during embryoid body (EB) 569 
formation, the process used as an intermediate step in the derivation of NSCs from 570 
ESCs (Nairn et al., 2007). In addition, the upregulation of NDST4 and 6-O-571 
sulfotransferase gene expression has been shown to be highly upregulated following 572 
neural differentiation of mouse ESCs indicating altered HS sulfation and subsequent 573 
changes in growth factor binding (Grobe et al., 2002, Johnson et al., 2007). With the 574 
increased expression of HS modifying enzymes correlating with the upregulation of 575 
neuronal markers, an importance for HS modifications during neuronal lineage 576 
commitment is highlighted (Oikari et al., 2015). 577 
 578 
Consistent with increased HS biosynthesis enzyme transcription, the increased 579 
expression of multiple cell surface HSPG core proteins, including SDC4, GPC1, 580 
GPC2, GPC3 and GPC6 were also observed following neuronal differentiation (Fig. 581 
7). Interestingly, SDC4 has previously been identified as glial-specific (Avalos et al., 582 
2009, Hsueh et al., 1998) with its upregulation in neuronal cultures suggesting it may 583 
also have a role in neuronal lineage specification. The importance of, in particular, 584 
GPC proteins in the neuronal lineage is supported by their coordinated expression 585 
with neuronal lineage markers (Oikari et al., 2015) and previous studies reporting the 586 
localisation of GPC1 and GPC2 to rodent neurons (Ford-Perriss et al., 2003, Ivins et 587 
al., 1997, Jen et al., 2009, Luxardi et al., 2007) as well as the reported upregulated 588 
expression of GPC2, -3 and -6 following mouse EB differentiation (Nairn et al., 2007, 589 
Zhang et al., 2001). Furthermore, in our study the downregulation of GPC1 in basal 590 
hNSC H9 cells resulted in reduced expression of TUBB3 and NEFM, further 591 
highlighting the importance of GPCs in neuronal lineage regulation.  592 
 593 
Markers and HSPGs of astrocyte differentiation  594 
 595 
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The observed low expression levels of glial markers (astrocyte and oligodendrocyte) 596 
in basal hNSC H9 cultures indicated low inherent glial differentiative potential of the 597 
cells. The oligodendrocyte cultures of hNSC H9 cells were not viable and the 598 
efficiency of astrocyte differentiation was difficult to determine, due to low expression 599 
levels of astrocyte lineage markers. However, the significantly increased expression 600 
of S100B following astrocyte differentiation compared to basal and neuronal cultures 601 
indicated astrocyte lineage commitment of the cells (Fig. 7). The NSC marker MSI1, 602 
previously reportedly expressed in reactive astrocytes (Oki et al., 2010) was also 603 
highly significantly upregulated in astrocyte differentiation conditions, potentially 604 
providing a new astrocyte specific marker (Fig. 7). With the glial marker CD44 605 
showing greater expression in the neuronal lineage cells, higher neuronal specificity 606 
for this marker is indicated (Fig. 7) reinforcing the requirement to define more 607 
accurate human astrocyte lineage markers.  608 
 609 
Expression of the HS biosynthesis enzymes showed few changes following astrocyte 610 
differentiation likely reflective of the lower efficiency of astrocyte differentiation. 611 
However, upregulation of NDST3 and HS6ST1 following astrocyte commitment 612 
again suggests the importance of HS modifications and the incorporation of 6-O-613 
sulfation sites during hNSC differentiation (Fig. 7). NDST3 has a more restricted 614 
expression profile than NDST1/2 but is expressed during embryonic development 615 
(Nairn et al., 2007). Low levels of NDST3 were observed in basal hNSC H9 cells and 616 
was upregulated following hNSC H9 (neuronal and astrocyte) lineage commitment 617 
suggesting NDST3 may play a role within the neural niche during lineage 618 
specification but not during stem cell maintenance.   619 
 620 
Our observed changes in the hNSC H9 HSPG profile following astrocyte 621 
differentiation suggest GPC4 as an astrocyte lineage marker (Fig. 7). GPC4 622 
expression at the gene expression levels was highly upregulated in astrocyte 623 
cultures with its IF localisation demonstrating a distinct “clustering” pattern that 624 
differed from basal and neuronal cultures. Additionally, KD of GPC4 in basal hNSC 625 
H9 cultures resulted in the downregulation of S100B further supporting its 626 
importance within astrocytes. Finally, the combination of GPC4 and GPC6 may be of 627 
importance in the astrocyte niche, as increased transcription of GPC6 was also 628 
observed in the astrocyte cultures compared to basal cultures, with previous studies 629 
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in rodents further supporting this hypothesis (Allen et al., 2012), Identification of 630 
regulators of the astrocyte lineage would greatly enhance the more efficient 631 
derivation of astrocytes from hNSCs. 632 
 633 
Conclusions 634 
 635 
Our data demonstrates hNSC H9 cells provide a good model to study human NSC 636 
self-renewal and neurogenesis and suggest HSPGs as important proteins of lineage 637 
specificity for these cells. The HSPG SDCs were highly expressed in basal hNSC H9 638 
cultures and lineage differentiation resulted in an altered HSPG profile with multiple 639 
GPC proteins likely playing a role in neuronal differentiation and GPC4 identified as 640 
a potential mediator of astrocyte differentiation. Overall, our results support the 641 
importance of HS modifications during lineage commitment and the requirement for 642 
continued reorganisation of the localised niche during lineage specification. 643 
Importantly, in combination with identified lineage markers, HSPGs provide 644 
additional markers of hNSC and neural cell lineage characterisation, and as cell 645 
surface proteins, key HSPGs may provide targets to enable the more efficient 646 
isolation, enrichment and potentially differentiation of hNSCs and neural cell 647 
lineages.  648 
 649 
  650 
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 840 
Figure legends: 841 
 842 
Figure 1. Expansion of hNSC H9 cells. A) Growth curve of hNSC H9 populations 843 
(POP1 and POP2) expanded to passage 31 (P31). Cells exhibit a linear growth 844 
pattern and maintain 60-80% viability. B) Phase contrast images (20X magnification, 845 
scale bar 130 µM) of hNSC H9 cells at P2, P5, P17 and P31 corresponding to an 846 
average of 2 days, 12 days, 52 days and 96 days in culture. C) Relative expression 847 
of hTERT in hNSC H9 cells at passages 2-5, 7-11 13-17, 21-23 and 27-31 (error 848 
bars = SEM). 849 
 850 
Figure 2. hNSC H9 cells express NSC self-renewal, neuronal, astrocyte and 851 
oligodendrocyte lineage markers throughout expansion. Averaged (POP1 and 852 
POP2) relative expression in hNSC H9 cultures of A) NSC markers nestin, SOX1, 853 
SOX2 and MSI1, B) neuronal markers TUBB3, MAP2, NEFM and DCX, C) astrocyte 854 
markers S100B and CD44 and D) oligodendrocyte markers GalC, Olig1 and Olig2 at 855 
passages 2-5, 7-11 13-17, 21-23 and 27-31 (error bars = SEM, * p<0.05, ** p<0.01, 856 
*** p<0.001). Immunofluorescence of E) NSC markers nestin and SOX2, neuronal 857 
marker TUBB3, astrocyte marker S100B and oligodendrocyte marker O1 in hNSC 858 
H9 cells at passages 5, 17 and 31, counterstained with DAPI (40X magnification, 859 
scale bar 130 µM). F) Average signal intensity of IF (error bars = SD). G) Western 860 
blot analysis of SOX2 at passage P3-P5, P7-P11, P13-P17, P21-P23 and P27-P31 861 
with GAPDH loading control. 862 
 863 
Figure 3. hNSC H9 cells express HSPGs and HS biosynthesis enzymes. Averaged 864 
(POP1 and POP2) relative expression in hNSC H9 cultures of  A) EXT1 and EXT2, 865 
B) N-deacetylase/N-sulfotransferases (NDST1-4), C) C5-Epimerase, D) 2-O/6-O 866 
sulfotransfereases, E) SDC 1-4 and F) GPC 1-4 and 6 at passages 2-5, 7-11, 13-17, 867 
21-23 and 27-31 (error bars = SEM, * p<0.05, ** p<0.01, *** p<0.001). G) 868 
Immunofluorescence of pan HS 10E4 epitope in hNSC H9 cells at P5, P17 and P31 869 
counterstained with DAPI (40X magnification, scale bar 130 µM). 870 
 871 
 26 
Figure 4. Neuronal and astrocyte differentiation of hNSC H9 cells alters cell 872 
morphology and marker expression. A) Neuronal and astrocyte lineage phase 873 
images of hNSC H9 P5 cells (20X and 40X magnification, scale bar 130 µM). 874 
Averaged (POP1 and POP2) relative expression of B) NSC C) neuronal and D) 875 
astrocyte markers and E) Western analysis of TUBB3, SOX2 and CD44 (GAPDH 876 
loading control) following neuronal and astrocyte differentiation. F) 877 
Immunofluorescence of nestin and SOX2, TUBB3 and S100B in hNSC H9, neuronal 878 
and astrocyte lineage cells (20X magnification, scale bar 130 µM) with average 879 
signal intensity graph (G). (Error bar = SD for CD44 relative expression astrocyte 880 
condition and average signal intensity graph, other error bars = SEM, * p<0.05, ** 881 
p<0.01, *** p<0.001.)    882 
 883 
Figure 5. HS biosynthesis enzymes and HSPG core protein (SDC and GPC) 884 
expression in hNSC H9 cells following neuronal and astrocyte lineage differentiation. 885 
Averaged (POP1 and POP2) relative expression of A) exostoses EXT1 and EXT2 886 
and C5-Epimerase, B) N-deacetylase/N-sulfotransferases and C) HS 2-O/6-O-887 
sulfotransferases D) SDC1-4 and E) GPC1-4, 6 following hNSC H9 neuronal and 888 
astrocyte differentiation (error bar for NDST3 basal hNSC H9 condition = SD, other 889 
error bars = SEM, * p<0.05, ** p<0.01, *** p<0.001). F-G) Western analysis and 890 
optical quantitation of the HS Δ3G10 epitope in basal and lineage differentiated cells. 891 
 892 
Figure 6. SDC4, GPC1 and GPC4 core proteins in hNSC H9 cell lineage 893 
specification. A) Immunofluorescence of SDC4, GPC1 and GPC4 in hNSC H9, 894 
neuronal and astrocyte lineage cells (20X magnification, scale bar 130 µM) with 895 
representative average signal intensity (error bars = SD). B) Relative expression of 896 
GPC1 and GPC4 and cell number and viability in control hNSC H9 P5 cells and in 897 
GPC1 and GPC4 knockdown (KD) cultures. Relative expression of C) NSC and D) 898 
neural lineage markers following GPC1 and GPC4 kd (error bars = SEM, * p<0.05, ** 899 
p<0.01, *** p<0.001). 900 
 901 
Figure 7. A schematic summary of changes in NSC and lineage markers (neuronal 902 
and glial), HS biosynthesis enzymes and HSPG core proteins in hNSC H9 cells. Key 903 
differences were identified between early (P2-P5) and late (P27-P31) passage 904 
cultures and following neuronal and astrocyte lineage differentiation.  905 
